Dragani A et al. |
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. |
2010 |
Blood |
pmid:19887674
|
Montine TJ et al. |
Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT. |
2010 |
PLoS ONE |
pmid:20174466
|
Dharmasaroja PA and Sae-Lim S |
Effects of different doses, enteric-coated preparation of aspirin, and sex on urinary 11-dehydrothromboxane B2 in healthy volunteers. |
2010 |
Blood Coagul. Fibrinolysis |
pmid:20689403
|
Yassine HN et al. |
Clinical determinants of aspirin resistance in diabetes. |
2010 |
Diabetes Res. Clin. Pract. |
pmid:20719400
|
Warner JH et al. |
Adaptive regression modeling of biomarkers of potential harm in a population of U.S. adult cigarette smokers and nonsmokers. |
2010 |
BMC Med Res Methodol |
pmid:20233412
|
Fukushima H et al. |
Mechanisms underlying early development of pulmonary vascular obstructive disease in Down syndrome: An imbalance in biosynthesis of thromboxane A2 and prostacyclin. |
2010 |
Am. J. Med. Genet. A |
pmid:20583254
|
Frisbee JC et al. |
Aspirin resistance with genetic dyslipidemia: contribution of vascular thromboxane generation. |
2010 |
Physiol. Genomics |
pmid:20530721
|
Antonino MJ et al. |
Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone. |
2010 |
Thromb. Res. |
pmid:19446864
|
Santilli F et al. |
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus. |
2010 |
J. Thromb. Haemost. |
pmid:20088941
|
Addad F et al. |
Response variability to aspirin and one-year prediction of vascular events in patients with stable coronary artery disease. |
2010 |
J. Thromb. Thrombolysis |
pmid:19381450
|